TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Evaluation of Oral Midazolam for Anxiety and Pain in First-trimester Surgical Abortion: a Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the level of pain, anxiety and side effects that women experience with a surgical abortion and the effect that the anti-anxiety medication, midazolam, might have when used along with ibuprofen and a paracervical block (PCB) instead of the standard pain treatment of only ibuprofen and a PCB.


Options:
A: Intervention Type: DRUG; Name: oxycodone + lorazepam versus fentanyl + midazolam; Assigned to Arm(s): N/A
B: Arm Label: Hydrocodone/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocodone/acetaminophen, Drug: Ibuprofen, Drug: Lorazepam, Drug: Lidocaine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Ibuprofen, Drug: Lorazepam, Drug: Lidocaine | Intervention Type: DRUG; Name: Hydrocodone/acetaminophen; Assigned to Arm(s): Hydrocodone/acetaminophen | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Hydrocodone/acetaminophen, Placebo | Intervention Type: DRUG; Name: Lorazepam; Assigned to Arm(s): Hydrocodone/acetaminophen, Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Hydrocodone/acetaminophen, Placebo
C: Arm Label: placebo-cherry syrup and ibuprofen; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ibuprofen, Other: Placebo-Cherry syrup, Drug: Lidocaine | Arm Label: Midazolam and ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam, Drug: Ibuprofen, Drug: Lidocaine | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam and ibuprofen | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Midazolam and ibuprofen, placebo-cherry syrup and ibuprofen | Intervention Type: OTHER; Name: Placebo-Cherry syrup; Assigned to Arm(s): placebo-cherry syrup and ibuprofen | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Midazolam and ibuprofen, placebo-cherry syrup and ibuprofen
D: Arm Label: No Paracervical Block for Pain Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Paracervical Block | Arm Label: Paracervical Block for Pain Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Paracervical Block | Intervention Type: PROCEDURE; Name: Paracervical Block; Assigned to Arm(s): Paracervical Block for Pain Control | Intervention Type: PROCEDURE; Name: Sham Paracervical Block; Assigned to Arm(s): No Paracervical Block for Pain Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collagen Cross-linking in Infectious Keratitis Trial
Brief Summary: The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.


Options:
A: Arm Label: Collagen cross-linking; Type: EXPERIMENTAL; Interventions: Procedure: Collagen cross-linking | Arm Label: standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Collagen cross-linking; Assigned to Arm(s): Collagen cross-linking
B: Arm Label: Bacterial ulcer cross-linking; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking | Arm Label: Bacterial ulcer control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking | Arm Label: Fungal ulcer cross-linking plus natamycin; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer control with natamycin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer cross-linking plus amphotericin; Type: EXPERIMENTAL; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Arm Label: Fungal ulcer control with amphotericin; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Corneal Cross-linking, Drug: Anti Fungal Drug | Intervention Type: PROCEDURE; Name: Corneal Cross-linking; Assigned to Arm(s): Bacterial ulcer control, Bacterial ulcer cross-linking, Fungal ulcer control with amphotericin, Fungal ulcer control with natamycin, Fungal ulcer cross-linking plus amphotericin, Fungal ulcer cross-linking plus natamycin | Intervention Type: DRUG; Name: Anti Fungal Drug; Assigned to Arm(s): Fungal ulcer control with amphotericin, Fungal ulcer control with natamycin, Fungal ulcer cross-linking plus amphotericin, Fungal ulcer cross-linking plus natamycin
C: Arm Label: Kpro with crosslinked graft-support; Type: EXPERIMENTAL; Interventions: Procedure: Crosslinking with riboflavin of the corneal graft-support | Arm Label: KPro with normal graft-support; Type: ACTIVE_COMPARATOR; Interventions: Procedure: De-epithelisation of the corneal graft support with instillation of riboflavin | Intervention Type: PROCEDURE; Name: Crosslinking with riboflavin of the corneal graft-support; Assigned to Arm(s): Kpro with crosslinked graft-support | Intervention Type: PROCEDURE; Name: De-epithelisation of the corneal graft support with instillation of riboflavin; Assigned to Arm(s): KPro with normal graft-support
D: Arm Label: antibiotic treatment alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: antibiotic treatment | Arm Label: Crosslinking + Antibiotic; Type: EXPERIMENTAL; Interventions: Device: Crosslinking, Drug: antibiotic treatment | Intervention Type: DEVICE; Name: Crosslinking; Assigned to Arm(s): Crosslinking + Antibiotic | Intervention Type: DRUG; Name: antibiotic treatment; Assigned to Arm(s): Crosslinking + Antibiotic, antibiotic treatment alone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acceptance and Biomarker Response With Oral vs. Intramuscular Supplementation of Vitamin B12 in Primary Care
Brief Summary: In this study, biomarker response after supplementation with oral and intramuscular vitamin B12 will be compared in a randomized clinical trial. Electronic compliance monitoring will be used to control for non compliance as a possible confounder in oral treatment. Additionally subjective acceptance in terms of presumed preferences will be compared with oral vs. intramuscular supplementation of vitamin B12 in the view of the patient.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: mecobalamin | Intervention Type: DRUG; Name: mecobalamin; Assigned to Arm(s): 1
B: Arm Label: i.m. injection of Vitamin B12; Type: ACTIVE_COMPARATOR; Interventions: Drug: i.m. injection of vitamin B12 | Arm Label: Oral administration of vitamin B12; Type: EXPERIMENTAL; Interventions: Drug: Oral administration of vitamin B12 | Intervention Type: DRUG; Name: Oral administration of vitamin B12; Assigned to Arm(s): Oral administration of vitamin B12 | Intervention Type: DRUG; Name: i.m. injection of vitamin B12; Assigned to Arm(s): i.m. injection of Vitamin B12
C: Arm Label: Oral Eligen® B12; Type: EXPERIMENTAL; Interventions: Other: Vitamin B12 (cyanocobalamin) | Arm Label: IM B12; Type: ACTIVE_COMPARATOR; Interventions: Other: Vitamin B12 (cyanocobalamin) | Intervention Type: OTHER; Name: Vitamin B12 (cyanocobalamin); Assigned to Arm(s): IM B12, Oral Eligen® B12
D: Intervention Type: DRUG; Name: Metformin on top of intensive insulin therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study Testing a Hatha Yoga Exercise Program in Older Women With Knee Osteoarthritis
Brief Summary: The study hypothesized that it is feasible and safe to use Hatha yoga in older women with knee osteoarthritis (OA), and practicing Hatha yoga regularly will help reduce pain and stiffness, enhance physical function, and improve quality of sleep and quality of life in older women with knee OA.


Options:
A: Arm Label: Patient education; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Patient education and supervised exercise | Arm Label: Patient education and supervised exercise; Type: EXPERIMENTAL; Interventions: Procedure: Patient education and supervised exercise | Intervention Type: PROCEDURE; Name: Patient education and supervised exercise; Assigned to Arm(s): Patient education, Patient education and supervised exercise
B: Arm Label: yoga intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Hatha yoga | Arm Label: wait list control; Type: OTHER; Interventions: Behavioral: Hatha Yoga | Intervention Type: BEHAVIORAL; Name: Hatha yoga; Assigned to Arm(s): yoga intervention | Intervention Type: BEHAVIORAL; Name: Hatha Yoga; Assigned to Arm(s): wait list control
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral graded activity | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise therapy | Intervention Type: BEHAVIORAL; Name: Behavioral graded activity; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Exercise therapy; Assigned to Arm(s): B
D: Intervention Type: BEHAVIORAL; Name: Tai Chi classes; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Hydrotherapy classes; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in Treatment-Naïve Adults With Genotype 1a Chronic Hepatitis C Virus (HCV) Infection (PEARL-IV)
Brief Summary: The purpose of this study is to evaluate the safety and antiviral activity of ABT-450/ritonavir/ABT- 267 (ABT-450/r/ABT-267; ABT-450 also known as paritaprevir; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) with and without ribavirin (RBV) in patients with chronic hepatitis C virus genotype 1a (HCV GT1a) infection without cirrhosis.


Options:
A: Arm Label: BI 207127 low dose + SOC; Type: EXPERIMENTAL; Interventions: Drug: BI 207127 low dose + SOC | Arm Label: BI 207127 middle dose +SOC; Type: EXPERIMENTAL; Interventions: Drug: BI 207127 middle dose +SOC | Arm Label: BI 207127 high dose+SOC; Type: EXPERIMENTAL; Interventions: Drug: BI 207127 high dose+SOC | Arm Label: Placebo + SOC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo + SOC | Intervention Type: DRUG; Name: BI 207127 middle dose +SOC; Assigned to Arm(s): BI 207127 middle dose +SOC | Intervention Type: DRUG; Name: BI 207127 high dose+SOC; Assigned to Arm(s): BI 207127 high dose+SOC | Intervention Type: DRUG; Name: Placebo + SOC; Assigned to Arm(s): Placebo + SOC | Intervention Type: DRUG; Name: BI 207127 low dose + SOC; Assigned to Arm(s): BI 207127 low dose + SOC
B: Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pegylated Interferon alfa-2b, Drug: Ribavirin, Drug: Sofosbuvir | Arm Label: Simeprevir + Sofosbuvir; Type: EXPERIMENTAL; Interventions: Drug: Simeprevir, Drug: Sofosbuvir | Intervention Type: DRUG; Name: Pegylated Interferon alfa-2b; Assigned to Arm(s): Standard | Intervention Type: DRUG; Name: Simeprevir; Assigned to Arm(s): Simeprevir + Sofosbuvir | Intervention Type: DRUG; Name: Ribavirin; Assigned to Arm(s): Standard | Intervention Type: DRUG; Name: Sofosbuvir; Assigned to Arm(s): Simeprevir + Sofosbuvir, Standard
C: Arm Label: SOF/VEL; Type: EXPERIMENTAL; Interventions: Drug: SOF/VEL | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SOF/VEL; Assigned to Arm(s): SOF/VEL | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: ABT-450/r/ABT-267 and ABT-333, Plus RBV; Type: EXPERIMENTAL; Interventions: Drug: ABT-450/r/ABT-267, ABT-333, Drug: Ribavirin | Arm Label: ABT-450/r/ABT-267 and ABT-333, Plus Placebo RBV; Type: EXPERIMENTAL; Interventions: Drug: ABT-450/r/ABT-267, ABT-333, Drug: Placebo for Ribavirin | Intervention Type: DRUG; Name: ABT-450/r/ABT-267, ABT-333; Assigned to Arm(s): ABT-450/r/ABT-267 and ABT-333, Plus Placebo RBV, ABT-450/r/ABT-267 and ABT-333, Plus RBV | Intervention Type: DRUG; Name: Ribavirin; Assigned to Arm(s): ABT-450/r/ABT-267 and ABT-333, Plus RBV | Intervention Type: DRUG; Name: Placebo for Ribavirin; Assigned to Arm(s): ABT-450/r/ABT-267 and ABT-333, Plus Placebo RBV

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Physical Activity in Latinas Via Interactive Web-Based Technology
Brief Summary: In this study, investigators are specifically targeting Latina women as they are more likely to be inactive and, therefore, are at higher risk for developing chronic conditions such as obesity, diabetes, or cardiovascular disease.

The objective of Pasos Hacia La Salud is to test a Spanish-language Internet-based Physical Activity Intervention, in comparison to a Spanish-language Internet-based Wellness Contact Control condition. Participants are randomly assigned to one of two groups (Exercise and General Wellness).

The investigators hypothesize that at the end of treatment, intervention participants will report significantly more minutes of moderate intensity physical activity per week than the wellness contact control participants.


Options:
A: Arm Label: Physical Activity Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Wellness Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Physical Activity Intervention | Intervention Type: BEHAVIORAL; Name: Wellness Control; Assigned to Arm(s): Wellness Control
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2
C: Arm Label: usual care plus Internet-based nutrition module; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based nutrition module along with usual care | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual care | Intervention Type: BEHAVIORAL; Name: Internet-based nutrition module along with usual care; Assigned to Arm(s): usual care plus Internet-based nutrition module | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): usual care
D: Arm Label: User intervention; Type: OTHER; Interventions: Behavioral: User intervention | Arm Label: Health professional intervention; Type: OTHER; Interventions: Behavioral: Health professional intervention | Intervention Type: BEHAVIORAL; Name: User intervention; Assigned to Arm(s): User intervention | Intervention Type: BEHAVIORAL; Name: Health professional intervention; Assigned to Arm(s): Health professional intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Physical Activity in Latinas Via Interactive Web-Based Technology
Brief Summary: In this study, investigators are specifically targeting Latina women as they are more likely to be inactive and, therefore, are at higher risk for developing chronic conditions such as obesity, diabetes, or cardiovascular disease.

The objective of Pasos Hacia La Salud is to test a Spanish-language Internet-based Physical Activity Intervention, in comparison to a Spanish-language Internet-based Wellness Contact Control condition. Participants are randomly assigned to one of two groups (Exercise and General Wellness).

The investigators hypothesize that at the end of treatment, intervention participants will report significantly more minutes of moderate intensity physical activity per week than the wellness contact control participants.


Options:
A: Arm Label: Short breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short breaks | Arm Label: Long breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Long breaks | Intervention Type: BEHAVIORAL; Name: Short breaks; Assigned to Arm(s): Short breaks | Intervention Type: BEHAVIORAL; Name: Long breaks; Assigned to Arm(s): Long breaks
B: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intervention | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: No intervention | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Control
C: Arm Label: Physical Activity Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Wellness Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Physical Activity Intervention | Intervention Type: BEHAVIORAL; Name: Wellness Control; Assigned to Arm(s): Wellness Control
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: CHOICES Intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CHOICES Intervention; Assigned to Arm(s): Intervention Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Exercise Training on Visceral Fat, Insulin Sensitivity, Β-cell Function and Triglyceride Kinetics in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
Brief Summary: This project examines the effects of a 4 month structured exercise intervention program in patients with non-alcoholic fatty liver disease (NAFLD). We will examine changes in total and depot-specific (i.e.in different tissues, liver, muscle and pancreas)fat. We will correlate these with measurements of the insulin from the liver. The hypothesis is that by reducing fat in these specific depots we can reduce insulin resistance and prevent progression to diabetes.


Options:
A: Arm Label: treatment group; Type: EXPERIMENTAL; Interventions: Drug: Vitamin E softgel | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Vitamin E softgel; Assigned to Arm(s): treatment group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo group
B: Arm Label: Ginseng trial; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Red ginseng | Intervention Type: DIETARY_SUPPLEMENT; Name: Red ginseng; Assigned to Arm(s): Ginseng trial
C: Arm Label: caffeine and chlorogeinc acid; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: caffeine and chlorogenic acid | Arm Label: caffeine; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: caffeine | Arm Label: chlorogenic acid; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: chlorogenic acid | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: caffeine and chlorogenic acid; Assigned to Arm(s): caffeine and chlorogeinc acid | Intervention Type: DIETARY_SUPPLEMENT; Name: caffeine; Assigned to Arm(s): caffeine | Intervention Type: DIETARY_SUPPLEMENT; Name: chlorogenic acid; Assigned to Arm(s): chlorogenic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Unsupervised exercise training | Arm Label: lifestyle counseling and exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Unsupervised exercise training; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): lifestyle counseling and exercise

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Exercise Training on Visceral Fat, Insulin Sensitivity, Β-cell Function and Triglyceride Kinetics in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
Brief Summary: This project examines the effects of a 4 month structured exercise intervention program in patients with non-alcoholic fatty liver disease (NAFLD). We will examine changes in total and depot-specific (i.e.in different tissues, liver, muscle and pancreas)fat. We will correlate these with measurements of the insulin from the liver. The hypothesis is that by reducing fat in these specific depots we can reduce insulin resistance and prevent progression to diabetes.


Options:
A: Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Unsupervised exercise training | Arm Label: lifestyle counseling and exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Unsupervised exercise training; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): lifestyle counseling and exercise
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Low glycemic load diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat diet | Intervention Type: BEHAVIORAL; Name: Low glycemic load diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat diet; Assigned to Arm(s): 2
C: Arm Label: Intensive exercise; Type: EXPERIMENTAL; Interventions: Other: Intensive exercise | Arm Label: Lifestyle counseling; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Regular exercise; Type: EXPERIMENTAL; Interventions: Other: Conventional exercise | Intervention Type: OTHER; Name: Intensive exercise; Assigned to Arm(s): Intensive exercise | Intervention Type: OTHER; Name: Conventional exercise; Assigned to Arm(s): Regular exercise
D: Arm Label: Glucose; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Glucose | Arm Label: Fructose; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Fructose | Intervention Type: DIETARY_SUPPLEMENT; Name: Glucose; Assigned to Arm(s): Glucose | Intervention Type: DIETARY_SUPPLEMENT; Name: Fructose; Assigned to Arm(s): Fructose

Answer: A